Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,565,000 | 13,242,000 | 6,841,000 | 12,694,000 | 8,096,000 |
| Marketable Securities | N/A | 447,000 | 252,000 | 498,000 | N/A |
| Receivables | 11,775,000 | 10,278,000 | 10,349,000 | 9,450,000 | 9,230,000 |
| Inventories | 6,658,000 | 6,109,000 | 6,358,000 | 5,911,000 | 5,953,000 |
| Other current assets | 10,518,000 | 8,706,000 | 8,368,000 | 7,169,000 | 6,987,000 |
| TOTAL | $43,516,000 | $38,782,000 | $32,168,000 | $35,722,000 | $30,266,000 |
| Non-Current Assets | |||||
| PPE Net | 25,316,000 | 23,779,000 | 23,051,000 | 21,422,000 | 19,279,000 |
| Investments And Advances | 956,000 | 463,000 | 252,000 | 1,015,000 | 370,000 |
| Intangibles | 48,260,000 | 38,038,000 | 39,208,000 | 41,473,000 | 44,197,000 |
| Other Non-Current Assets | 18,818,000 | 16,044,000 | 11,996,000 | 9,528,000 | 11,582,000 |
| TOTAL | $93,350,000 | $78,324,000 | $74,507,000 | $73,438,000 | $75,428,000 |
| Total Assets | $136,866,000 | $117,106,000 | $106,675,000 | $109,160,000 | $105,694,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,404,000 | 4,079,000 | 3,922,000 | 4,264,000 | 4,609,000 |
| Accrued Expenses | 14,468,000 | 15,694,000 | 15,766,000 | 14,159,000 | 13,859,000 |
| TOTAL | $28,327,000 | $28,420,000 | $25,694,000 | $24,239,000 | $23,872,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 46,750,000 | 34,462,000 | 33,683,000 | 28,745,000 | 30,690,000 |
| Other Non-Current Liabilities | 7,679,000 | 6,449,000 | 8,780,000 | 8,316,000 | 9,421,000 |
| TOTAL | $55,877,000 | $42,314,000 | $43,346,000 | $38,863,000 | $43,565,000 |
| Total Liabilities | $84,204,000 | $70,734,000 | $69,040,000 | $63,102,000 | $67,437,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,472,392 | 2,526,036 | 2,532,644 | 2,538,593 | 2,527,734 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 |
| Retained earnings | 73,075,000 | 63,069,000 | 53,895,000 | 61,081,000 | 53,696,000 |
| Other shareholders' equity | -4,231,000 | -4,886,000 | -5,107,000 | -4,701,000 | -4,356,000 |
| TOTAL | $52,662,000 | $46,372,000 | $37,635,000 | $46,058,000 | $38,257,000 |
| Total Liabilities And Equity | $136,866,000 | $117,106,000 | $106,675,000 | $109,160,000 | $105,694,000 |